The induction of Mitsuda type of late response by tuberculin in patients with pulmonary tuberculosis and its significance


Original Article

Author Details : R Velraj*, Raj Thilak R, Anusuya A

Volume : 5, Issue : 2, Year : 2020

Article Page : 105-109

https://doi.org/10.18231/j.ijirm.2020.039



Suggest article by email

Get Permission

Abstract

Background: Traditionally, the kinetics of tuberculin testing has been studied up to 72 hours. In this study,
we have studied the Mitsuda type of late response, usually seen in patients with leprosy after three weeks
and also evaluated its significance in patients with pulmonary tuberculosis.
Materials and Methods: Thirty patients of pulmonary tuberculosis were divided into two groups based on
sputum Acid-fast bacilli (AFB) examination. Group I patients were sputum AFB positive relapse (n=13).
Group II patients were previously treated for pulmonary tuberculosis with negative sputum AFB (n=17).
The induration was measured on day 3 and day 21, after tuberculin test with Purified protein derivative
(PPD). A punch biopsy was taken from the site of induration on day 21 to study the histo-pathological
characteristics.
Results: Four patients (23.5%) of Group 2 had an induration of more than 10 mm on day 21, while none
from Group I had more than 10 mm size of induration. Granulomas, typical feature of ‘Mitsuda’ type of
late response were seen in 92% and 100% in Group I and II respectively. The incidence of a granulomatous
type of late response is 96.7% in patients with pulmonary tuberculosis.
Conclusions: The Mitsuda type of late response can be induced by the PPD, which we are using for
conventional tuberculin testing. The late response appears to offer no protection in preventing relapse in
previously treated patients for pulmonary tuberculosis.

Keywords: Mitsuda response, Tuberculin test, Pulmonary tuberculosis, Relapse.


How to cite : Velraj R, Raj Thilak R, Anusuya A, The induction of Mitsuda type of late response by tuberculin in patients with pulmonary tuberculosis and its significance. IP Indian J Immunol Respir Med 2020;5(2):105-109


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.







View Article

PDF File   Full Text Article


Copyright permission

Get article permission for commercial use

Downlaod

PDF File   XML File   ePub File


Digital Object Identifier (DOI)

Article DOI

https://doi.org/10.18231/j.ijirm.2020.039


Article Metrics






Article Access statistics

Viewed: 1081

PDF Downloaded: 536



Medical Abbreviation List